Studies on the interactions between the intestinal microbiome and its host have strengthened in the last decade. However, publications on this topic in dogs still need to be made available, reinforcing the need for new studies and literary data for consultation. Given this, this review aims to describe the intestinal microbiome and its interactions with the canine host, which can contribute to both health and morbid conditions in these animals. The definition of microbiome encompasses the collective genome of all microorganisms that live in a defined habitat (intestine). It is known that the dog’s intestinal microbiota is varied, composed of bacteria, archaea, viruses, fungi, and protozoa. Under normal conditions, there is commensalism between some of these microorganisms and the host, which promotes critical physiological relationships and interactions that contribute to homeostasis and the consequent health of the animal. With this in mind, it is expected that the disturbances associated with the microbiome will result in imbalances in this commensal relationship and thus precipitate the development of diseases and aggravation of other diseases, thus characterizing intestinal dysbiosis.
9 November 2025 in Journal of Hospital Pharmacy and Health Services
Objective: To compare incident reporting associated with generic and branded docetaxel in a Brazilian teaching hospital, and to analyze the pharmacovigilance notifications involving this drug in a teaching hospital. Methods: A cross-sectional study was conducted in a high complexity Brazilian university hospital. Data from patients aged 18 years or older were included. Incidents associated with docetaxel 80 mg reported in the hospital’s pharmacovigilance database from January 1st, 2018, to December 31st, 2020, were analyzed. Reports of adverse drug reactions (ADR), therapeutic ineffectiveness, medication errors, and quality deviations (QD) were considered. Additionally, the underreporting rate of late ADRs was calculated. For descriptive analysis it was used the number of cases and percentages for categorical variables; and mean and standard deviation (SD) for continuous variables. Results: 124 incident reports related to chemotherapeutic agents were recorded. Among these, 34 (27.4%) were associated with docetaxel. Two involved the generic medication, while 32 were associated with the branded medication. Despite having a well-established multidisciplinary team in the oncology department, the most frequent reporters were nurses (26/34). The reports described 35 incidents: 21 ADR (10 immediate and 11 delayed) and 14 QD. Nine immediate ADR, 11 delayed ADR, and 12 QD reports were related to branded medication. The underreporting rate was 93.0%. Conclusion: Underreporting hindered the comparison of incidentes associated with generic and branded docetaxel in the pharmacovigilance database. The lack of medication safety communication decreases signal detection and compromises decision-making rely on real-world data. In this regard, the findings suggest the need for educational interventions for healthcare professionals to improve attitudes towards pharmacovigilance.